P3 HEALTH PARTNERS INC - PIII STOCK NEWS

P3 Health Partners (NASDAQ: PIII) has announced preliminary guidance for 2025 and a proposed financing transaction. The company targets profitability in 2025 with projected revenues between $1.350 billion and $1.500 billion and Adjusted EBITDA ranging from negative $35 million to positive $5 million. CEO Aric Coffman noted that the company is on track with its $130+ million EBITDA growth initiatives and expects to issue full 2025 guidance with Q4 2024 earnings.

P3 is in discussions for a $30 million unsecured promissory note and warrants, similar to a December 2024 transaction. This financing is subject to approval by independent directors and final documentation. The guidance includes an estimated 108,000 to 118,000 at-risk members by the end of 2025. The company emphasizes that these projections are subject to change based on various factors, and no obligation to update estimates is assumed.

P3 Health Partners (NASDAQ: PIII), a patient-centered and physician-led population health management company, will participate in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, California. The company's management will deliver a presentation on Tuesday, January 14, 2024, at 7:30 AM Pacific Time. A webcast of the presentation will be accessible on P3’s Investor Relations Website at https://ir.p3hp.org/. Additionally, a replay of the presentation will be available on the same webpage for 30 days following the event.

P3 Health Partners (NASDAQ: PIII), a patient-centered and physician-led population health management company, has announced its participation in the Noble Capital Markets 20th Annual Emerging Growth Equity Conference. The company's management will deliver a presentation on Tuesday, December 3, 2024, at 3:30 pm Eastern Time in Boca Raton, FL. Interested parties can access a live webcast of the presentation the following day through P3's Investor Relations Website at https://ir.p3hp.org/.

P3 Health Partners (NASDAQ: PIII), a patient-centered and physician-led population health management company, has announced its participation in two upcoming investor conferences. The company will attend the 3rd Annual Needham Virtual Healthcare IT 1x1 Conference on Wednesday, November 20, 2024, and the BTIG Digital Health Forum on Monday, November 25, 2024.

P3 Health Partners (NASDAQ: PIII) announced its financial results for Q3 2024, ending September 30, 2024. Revenue increased by 26% YoY to $362.1 million. Capitated revenue rose by 25% to $357.7 million. However, the company reported a gross profit loss of $39.8 million, compared to a gross profit of $9.1 million in the previous year. The medical margin was $0.5 million, down from $36.2 million last year. Net loss widened to $102.9 million, up from $37.3 million. Adjusted EBITDA loss was $71.0 million, compared to $22.3 million in Q3 2023. Due to lower-than-expected risk adjustments and elevated medical costs, the company is withdrawing its previous FY 2024 guidance. Management will host a conference call on November 12, 2024, at 4:30 PM ET to discuss these results.

P3 Health Partners (NASDAQ: PIII), a patient-centered and physician-led population health management company, has announced its upcoming third quarter 2024 financial results release and conference call. The company will release its Q3 2024 results and file its Quarterly Report on Form 10-Q on Tuesday, November 12, 2024. Management will host a conference call at 4:30 PM ET the same day to discuss the results. The call will be accessible via toll-free number 1-833-316-0546 (US) or international number 1-412-317-0692, and will also be webcast live on the company's investor website.

P3 Health Partners Inc. (NASDAQ: PIII), a patient-centered and physician-led population health management company, has announced its participation in the LD Micro Main Event XVII Conference. The event is scheduled for Wednesday, October 30, 2024, in Los Angeles, CA.

The company's management team will deliver a presentation at 2:30 pm Eastern Time. Interested parties can access a live webcast of the presentation through P3's Investor Relations Website at https://ir.p3hp.org/.

This conference appearance provides an opportunity for P3 Health Partners to showcase its business model and strategies to potential investors and industry professionals.

P3 Health Partners (NASDAQ: PIII) has announced the appointment of Leif Pedersen as its new Chief Financial Officer, effective October 1, 2024. Pedersen, with over 25 years of experience in finance and value-based care, will succeed Atul Kavthekar, who will transition to a Strategic Advisor role. Pedersen's background includes serving as VP of Finance & CFO Shared Services at Optum Health and VP of Finance & CFO IT at DaVita Medical Group.

In his new role, Pedersen will oversee Accounting, Treasury, Finance Analytics, and Investor Relations. P3's CEO, Dr. Aric Coffman, expressed confidence in Pedersen's ability to help the company achieve its long-term goals while maintaining excellence in value-based care.

P3 Health Partners (NASDAQ: PIII), a patient-centered and physician-led population health management company, has announced its participation in two upcoming investor conferences. The company will be present at:

• The 2024 Wells Fargo Healthcare Conference in Boston, MA on Wednesday, September 4, 2024
• The Lake Street Best Ideas Growth Conference in New York, NY on Thursday, September 12, 2024

These conferences provide P3 Health Partners with opportunities to showcase their business model and growth strategies to potential investors and industry analysts. The company's presence at these events underscores its commitment to engaging with the investment community and highlighting its role in the evolving healthcare landscape.